alzres.com/content
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Alzheimer's Research & Therapy
tracked for impact factor
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Alzheimer's Research & Therapy
  • Subscriptions

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
  • Issues
  • Supplements
  • Article collections

The new FTD mutation on chromosome 9

Collection published: 19 July 2012

Last updated: 18 February 2013


Editorial   Free

The C9ORF72 mutation brings more answers and more questions

Bruce L Miller Alzheimer's Research & Therapy 2013, 5:7 (18 February 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Bruce Miller, Guest Editor of the special series: The new FTD mutation on chromosome 9, discusses the C9ORF72 mutation associated with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis.

Commentary   Subscription

Assessment of psychiatric changes in C9ORF72 frontotemporal dementia

Michael Hornberger Alzheimer's Research & Therapy 2012, 4:49 (24 December 2012)

Abstract | Full text | PDF | PubMed

Review   Subscription

Treatment implications of C9ORF72

Sharon J Sha, Adam Boxer Alzheimer's Research & Therapy 2012, 4:46 (27 November 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Sha and Boxer discuss the animal models and research tools needed to understand the clinical phenotypes of frontotemporal dementia and amyotrophic lateral sclerosis linked to chromosome 9 (c9FTD/ALS) in C9ORF72-mediated disease.

Review   Subscription

Neuroimaging features of C9ORF72 expansion

Jennifer S Yokoyama, Howard J Rosen Alzheimer's Research & Therapy 2012, 4:45 (16 November 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Yokoyama and Rosen review neuroimaging studies on the pathogenic C9ORF72 expansion; establishing that unique characteristics of C9ORF72-associated disease may aid identification of patients for genetic screening and diagnosis.

Review   Subscription

Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease

Leonel T Takada, Sharon J Sha Alzheimer's Research & Therapy 2012, 4:38 (3 October 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Takada and Sha review the neuropsychiatric features of chromosome 9p-linked frontotemporal dementia (FTD) and the risk that some C9orf72 mutation carriers may be misdiagnosed with primary psychiatric conditions.

Commentary   Subscription

C9orf72 immunohistochemistry in Alzheimer's disease

Tibor Hortobágyi Alzheimer's Research & Therapy 2012, 4:37 (26 September 2012)

Abstract | Full text | PDF | PubMed

Research   Open Access

Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions

Colin J Mahoney, Laura E Downey, Gerard R Ridgway, Jon Beck, Shona Clegg, Melanie Blair, Sarah Finnegan, Kelvin K Leung, Tom Yeatman, Hannah Golden, Simon Mead, Jonathan D Rohrer, Nick C Fox, Jason D Warren Alzheimer's Research & Therapy 2012, 4:41 (24 September 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Longitudinal neuropsychological and neuroimaging data on a cohort of patients with pathological repeat expansions in C9ORF72 is assessed, demonstrating longitudinal biomarkers for tracking the evolution of the C9ORF72 mutation phenotype.

Research   Open Access

Dystrophic neurites express C9orf72 in Alzheimer's disease brains

Jun-ichi Satoh, Hiroko Tabunoki, Tsuyoshi Ishida, Yuko Saito, Kunimasa Arima Alzheimer's Research & Therapy 2012, 4:33 (16 August 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

C9orf72 and UBQLN-1 expression in a cluster of dystrophic neurites in senile plaques in Alzheimer's disease brains suggests C9orf72 has a role in the process of neurodegeneration.

Research   Open Access

Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion

Laura E Downey, Colin J Mahoney, Martin N Rossor, Sebastian J Crutch, Jason D Warren Alzheimer's Research & Therapy 2012, 4:42 (13 August 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review   Subscription

Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia

Jennifer C Schymick, Bryan J Traynor Alzheimer's Research & Therapy 2012, 4:30 (26 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review   Subscription

Cognitive and behavioral features of c9FTD/ALS

Bradley F Boeve, Neill R Graff-Radford Alzheimer's Research & Therapy 2012, 4:29 (20 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Boeve and Graff-Radford review the major new findings in familial frontotemporal dementia and/or amyotrophic lateral sclerosis linked to chromosome 9 (c9FTD/ALS) and its recently discovered pathogenic C9ORF72 hexanucleotide expansion.

Review   Subscription

Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion

Jamie C Fong, Anna M Karydas, Jill S Goldman Alzheimer's Research & Therapy 2012, 4:27 (19 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Fong and colleagues discuss the genetic counselling considerations for individuals and their families considering genetic testing for the pathogenic C9ORF72 hexanucleotide expansion in familial frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.